EDITOR:
We read with interest Drs Martin-Castro and Montero’s report on the use of the flexible laryngeal mask (FLMA) as an alternative to reinforced tracheal tube for upper chest, head and neck oncoplastic surgery [Reference Martin-Castro and Montero1]. We seek some clarifications from them with regard to the operations concerned. How many of the patients whose airways were managed with the FLMA had oro-pharyngeal malignancies? What reconstructions were performed? Were there any postoperative tracheal intubations?
The term ‘head and neck oncoplastic surgery’ conventionally refers to resection of head, face and neck (or oral, pharyngeal and laryngeal) tumours followed by reconstruction using local, regional or microvascular free tissue flaps [Reference Eipe2]. These tumours often result in anticipated difficult airways and additionally may require nasotracheal and/or fibreoptic intubation or preoperative tracheotomy [Reference Mishra, Bhatnagar, Jha and Singhal3–Reference Kruse-Lösler, Langer, Reich, Joos and Kleinheinz5]. Airway management decisions are also based on the complexity of the planned reconstruction or the need for postoperative ventilation [Reference Eipe, Choudhrie, Pillai and Choudhrie6]. In our opinion, the airway management in head and neck oncoplastic surgery differs from upper chest (specifically breast oncoplastic) surgery. In the former, the laryngeal mask airway device can be used to temporarily secure the airway, as a conduit for fibreoptic intubation or offer a rescue technique before or after surgery. Therefore, while the FLMA, as these authors have reported, would be useful for breast oncoplastic surgery, it may have a limited role in the perioperative airway management for head and neck oncoplastic surgery.
